Table 1 Details of the subjects
Subject number | Age, sex | Findings in thyroid ultrasonography | TSH (μIU/mL) | FT4 (ng/dL) | FT3 (pg/mL) | L-T4 replacement dose (μg/day) | Tg-Ab (IU/mL) | TPO-Ab (IU/mL) | SUV max | Interval Between FDG-PET and thyroid test (days) |
|---|---|---|---|---|---|---|---|---|---|---|
Diffuse uptake | ||||||||||
1 | 51 F | Hetero, Hypo | 22.43 | 1.06 | 2.20 | 0 | 143 | 22 | 3.322 | 13 |
2 | 78 F | Hetero | 6.73 | 0.78 | 2.08 | 0 | > 4000 | 487 | 8.125 | 11 |
3 | 68 F | Hetero, Hypo | 73.06 | 0.57 | 2.37 | 25 | > 4000 | 16 | 3.741 | 28 |
4 | 59 F | Hetero | 6.43 | 0.93 | 3.21 | 0 | n.a. | 184 | 6.070 | 64 |
5 | 80 M | Rough, Hetero | 28.59 | 1.07 | 2.56 | 0 | > 4000 | > 600 | 5.714 | 3 |
6 | 86 F | Hetero | 21.04 | 0.68 | 1.75 | 12.5 | 476 | 53 | 3.354 | 1 |
7 | 64 F | Hetero | 3.79 | 1.32 | 1.16 | 0 | 122 | 29 | 2.923 | 1 |
8 | 66 M | Hetero, Hypo | 8.45 | 0.93 | 2.64 | 0 | > 4000 | > 600 | 6.165 | 21 |
9 | 78 F | Rough, Hetero | 87.87 | 0.50 | 1.50 | 25 | n.a. | > 600 | 12.023 | 4 |
10 | 41 F | Rough, Homo | 46.21 | 0.94 | 1.58 | 125 | 626 | > 600 | 9.985 | 3 |
11 | 43 F | Hetero | 3.24 | 1.31 | 2.49 | 0 | 537 | 332 | 4.113 | 7 |
12 | 67 F | Rough, Hetero | 25.11 | 0.94 | 3.04 | 0 | 2940 | 184 | 3.340 | 24 |
13 | 63 M | Rough, Hetero | 266.1 | 0.19 | 1.16 | 0 | 1360 | 72 | 3.868 | 19 |
Without diffuse uptake | ||||||||||
14 | 74 F | Homo | 0.033 | 1.23 | 3.12 | 0 | 147 | 10 | 2.492 | 10 |
15 | 68 F | Homo | 11.01 | 1.09 | 2.45 | 0 | 465 | 8 | 2.364 | 39 |
16 | 50 M | Homo | 5.38 | 0.96 | 2.15 | 0 | 18 | 22 | 1.535 | 14 |
17 | 80 F | Homo | 12.27 | 1.56 | 0.89 | 100 | 18 | 16 | 1.337 | 1 |
18 | 74 M | Fine, Homo | 11.23 | 1.11 | 2.39 | 0 | 16 | 18 | 1.704 | 83 |